Intel Corp
Intel’s wild week leaves Wall Street more uncertain than ever about chipmaker’s future
Intel CEO Patrick Gelsinger speaks at the Intel Ocotillo Campus in Chandler, Arizona, on March 20, 2024. Brendan Smialowski | AFP | Getty Images It was quite a week for Intel. The chipmaker, which has lost over half its value this year and last month had its worst day on the market in 50 years […]
Read More
Intel shares pop on report Qualcomm has approached it about takeover
Qualcomm CEO Cristiano Amon speaks at COMPUTEX forum in Taipei, Taiwan June 3, 2024. Ann Wang | Reuters Qualcomm approached Intel about a takeover in recent days, the Wall Street Journal reported on Friday, citing people familiar with the matter. Intel shares rose 8% on the report. The deal, if it were to happen, would […]
Read More
Stocks making the biggest moves midday: Gannett, Accenture, Hewlett Packard and more
Check out the companies making headlines in midday trading: Hewlett Packard Enterprise — The tech hardware stock jumped 6% after Bank of America upgraded the stock to a buy rating from neutral. The Wall Street firm believes the stock’s valuation is now “compelling,” while highlighting a slew of positive catalysts including new Chief Financial Officer […]
Read More
S&P 500 jumps to record ahead of key Fed decision on interest rates: Live updates
Traders work on the floor of the New York Stock Exchange. Brendan Mcdermid | Reuters The S&P 500 hit a record high Tuesday as the market awaited the Federal Reserve’s key interest rate cut decision. The broad market index was last up 0.4% at the 5,650 level, after earlier touching a new record high of […]
Read More
Stocks making the biggest moves premarket: Microsoft, Intel, Shopify and more
Check out the companies making headlines before the bell. Microsoft — Shares were up about 2% after the tech giant increased its quarterly dividend by 10.7% to 83 cents per share. The new dividend is payable Dec. 12. The company also approved a new $60 billion share repurchase program. SolarEdge Technologies — Shares fell more than […]
Read More
CNBC Daily Open: Tech might not be the biggest beneficiary of rate cuts
The sun rises behind the skyline of lower Manhattan and One World Trade Center on September 14, 2024, in Jersey City, New Jersey. Gary Hershorn | Corbis News | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need […]
Read More
Biden administration awards Intel up to $3 billion under the CHIPS Act
Intel CEO Pat Gelsinger delivers a speech at Taipei Nangang Exhibition Center during Computex 2024, in Taipei on June 4, 2024. I-Hwa Cheng | AFP | Getty Images The Biden administration on Monday awarded Intel up to an additional $3 billion under the CHIPS and Science Act for the “Secure Enclave” program, which is designed […]
Read More
Intel stock jumps on plan to turn foundry business into subsidiary and allow for outside funding
Intel CEO Pat Gelsinger holds a sample of a wafer during his keynote speech at the Computex conference in Taipei on June 4, 2024. I-hwa Cheng | AFP | Getty Images Intel shares jumped 8% in extended trading on Monday after the company said it plans to turn its foundry business into an independent unit […]
Read More
Here are the stocks that win when the Fed cuts rates with no recession
As investors gear up for this week’s Federal Reserve meeting, CNBC Pro found stocks that have historically done well when rates are cut without a recessionary environment. Fed funds futures have fully priced in that the central bank will lower interest rates, according to CME’s FedWatch Tool . The question now is how big that […]
Read More
Stocks making the biggest moves midday: Nuvalent, Alcoa, Sprouts Farmers Market, Apple and more
Check out the companies making headlines in midday trading: Nuvalent — Shares soared more than 22%, hitting an all-time high, after the biopharmaceutical company highlighted positive data on two experimental cancer treatments over the weekend. Nuvalent said the two drugs show “favorable tolerability.” Bausch + Lomb — The contact lens provider rallied 13.9% after the […]
Read More